3,693 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Bought by Krilogy Financial LLC

Krilogy Financial LLC acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) in the 2nd quarter, HoldingsChannel.com reports. The fund acquired 3,693 shares of the medical equipment provider’s stock, valued at approximately $741,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ISRG. BlackRock Inc. raised its holdings in Intuitive Surgical by 197.3% during the fourth quarter. BlackRock Inc. now owns 26,538,660 shares of the medical equipment provider’s stock worth $9,535,341,000 after purchasing an additional 17,612,768 shares during the last quarter. State Street Corp raised its holdings in shares of Intuitive Surgical by 209.4% in the fourth quarter. State Street Corp now owns 14,834,746 shares of the medical equipment provider’s stock worth $5,330,124,000 after acquiring an additional 10,040,407 shares during the last quarter. Capital World Investors raised its holdings in shares of Intuitive Surgical by 165.4% in the fourth quarter. Capital World Investors now owns 9,658,541 shares of the medical equipment provider’s stock worth $3,470,421,000 after acquiring an additional 6,018,962 shares during the last quarter. Alliancebernstein L.P. raised its holdings in shares of Intuitive Surgical by 238.2% in the fourth quarter. Alliancebernstein L.P. now owns 6,287,228 shares of the medical equipment provider’s stock worth $2,259,001,000 after acquiring an additional 4,428,375 shares during the last quarter. Finally, Jennison Associates LLC raised its holdings in shares of Intuitive Surgical by 124.8% in the first quarter. Jennison Associates LLC now owns 5,473,854 shares of the medical equipment provider’s stock worth $1,651,352,000 after acquiring an additional 3,038,455 shares during the last quarter. 82.44% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 9,000 shares of the company’s stock in a transaction dated Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total value of $2,025,000.00. Following the completion of the sale, the executive vice president now owns 217 shares of the company’s stock, valued at $48,825. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, Director Amal M. Johnson sold 6,375 shares of the company’s stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $210.76, for a total value of $1,343,595.00. Following the completion of the sale, the director now owns 11,224 shares of the company’s stock, valued at $2,365,570.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Myriam Curet sold 9,000 shares of the company’s stock in a transaction dated Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total value of $2,025,000.00. Following the completion of the sale, the executive vice president now directly owns 217 shares of the company’s stock, valued at approximately $48,825. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 101,162 shares of company stock valued at $22,062,916. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 2.0 %

ISRG stock opened at $191.08 on Friday. The stock has a 50-day moving average price of $219.31 and a two-hundred day moving average price of $233.72. Intuitive Surgical, Inc. has a 12-month low of $186.83 and a 12-month high of $369.69. The company has a market cap of $68.24 billion, a PE ratio of 48.62, a price-to-earnings-growth ratio of 5.43 and a beta of 1.31.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last posted its quarterly earnings results on Thursday, July 21st. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.04 by ($0.19). Intuitive Surgical had a net margin of 24.05% and a return on equity of 12.04%. The firm had revenue of $1.52 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same period last year, the firm posted $1.42 EPS. Equities analysts forecast that Intuitive Surgical, Inc. will post 3.76 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently weighed in on ISRG. Truist Financial cut their price target on Intuitive Surgical from $270.00 to $255.00 and set a “buy” rating for the company in a report on Friday, July 22nd. Stifel Nicolaus boosted their price target on Intuitive Surgical from $250.00 to $260.00 and gave the stock a “buy” rating in a report on Friday, September 9th. The Goldman Sachs Group cut their price target on Intuitive Surgical from $319.00 to $273.00 and set a “buy” rating for the company in a report on Friday, July 29th. Piper Sandler upped their target price on Intuitive Surgical from $255.00 to $260.00 and gave the company an “overweight” rating in a research note on Thursday, August 18th. Finally, Evercore ISI dropped their target price on Intuitive Surgical from $210.00 to $175.00 in a research note on Friday, July 22nd. Six investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $268.00.

About Intuitive Surgical

(Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.